Brainsway Ltd.
(NASDAQ : BWAY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 0.47%23.386.3%$1311.41m
TMOThermo Fisher Scientific, Inc. -1.32%382.561.0%$555.58m
DXCMDexCom, Inc. -0.20%439.648.2%$525.71m
MDTMedtronic Plc 0.77%90.820.6%$523.27m
BDXBecton, Dickinson & Co. -0.50%257.331.0%$495.38m
ABTAbbott Laboratories -0.67%93.040.8%$494.90m
DHRDanaher Corp. -0.95%183.700.7%$446.67m
BSXBoston Scientific Corp. 0.52%34.681.0%$429.44m
QDELQuidel Corp. 0.69%246.647.7%$412.12m
ISRGIntuitive Surgical, Inc. 0.24%575.872.4%$333.95m
SYKStryker Corp. 0.07%177.891.3%$308.55m
BAXBaxter International, Inc. -0.53%85.241.8%$275.66m
ALGNAlign Technology, Inc. -0.29%273.296.4%$224.28m
ZBHZimmer Biomet Holdings, Inc. 1.52%119.431.7%$205.29m
BIOBio-Rad Laboratories, Inc. -0.03%477.902.9%$199.18m

Company Profile

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.